Pure Global

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation - Trial NCT01952743

Access comprehensive clinical trial information for NCT01952743 through Pure Global AI's free database. This phase not specified trial is sponsored by Siva Mulpuru and is currently Terminated. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 3 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT01952743
Terminated
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT01952743
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation
Concomitant Renal Denervation Therapy in Hypertensive Patients Undergoing Atrial Fibrillation Ablation - A Feasibility Study

Study Focus

AF ablation with Renal Denervation

Interventional

procedure

Sponsor & Location

Siva Mulpuru

Mayo Clinic

Rochester, United States of America

Timeline & Enrollment

N/A

Sep 01, 2013

Oct 01, 2015

3 participants

Primary Outcome

Atrial fibrillation (AF) Time to recurrence and Burden,Hypertension control

Summary

We propose a pilot study to assess safety and benefit of renal artery ablation at the time of
 planned atrial fibrillation ablation.

ICD-10 Classifications

Chronic atrial fibrillation
Persistent atrial fibrillation
Paroxysmal atrial fibrillation
Atrial fibrillation and flutter
Atrial fibrillation and atrial flutter, unspecified

Data Source

ClinicalTrials.gov

NCT01952743

Non-Device Trial